期刊文献+

减低强度预处理亲缘间单倍体相合非体外去T细胞外周血造血干细胞移植治疗自体造血干细胞移植后复发的霍奇金淋巴瘤一例 被引量:1

Reduced-intensity conditioning haploidentical peripheral blood hematopoietic stem cell transplantation without T-cell depletion in vitro for treatment of relapsed Hodgkin lymphoma after autologous hematopoietic stem cell transplantation: report of one case
原文传递
导出
摘要 患者 男性,28岁,于2010年8月发现左侧颈部淋巴结肿大,淋巴结活组织检查确诊为霍奇金淋巴瘤(HL),结节硬化型Ⅳ期B。给予10次ABVD方案化疗,获完全缓解(CR),于2011年1月初行干细胞动员,1月底回输自体造血干细胞,移植后于2011年3月、4月分别行局部(脾脏、双侧锁骨下)放疗,并行干扰素、白细胞介素2治疗。2011年5月后均未复查随诊。
作者 王炳晨 李文婷 Wang Bingchen;Li Wenting(Teaching and Research Office of Clinical Internal Medicine,Heze Medical College,Heze 274000,China(Wang BC;Department of Hematology,Affiliated Hospital of Heze Medical College,Heze 274000,China;Department of Gynecologic Oncology,Heze Municipal Hospital,Heze 274000,China)
出处 《白血病.淋巴瘤》 CAS 2018年第9期557-558,576,共3页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献1

二级参考文献19

  • 1蔡宇,王椿,杨隽,颜式可,蔡琦,高彦荣,姜杰玲.抗CD_(20)单克隆抗体在非霍奇金淋巴瘤治疗中的应用[J].白血病.淋巴瘤,2005,14(3):145-147. 被引量:8
  • 2Schmitz N, Pfistner B, Sextro M, et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet, 2002, 359: 2065-2071.
  • 3Linch DC, Winfield D, Goldstone AH, et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet, 1993, 341: 1051-1054.
  • 4Baetz T, Belch A, Couban S, et al. Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase Ⅱ study by the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol, 2003, 14: 1762-1767.
  • 5Aparicio J, Segura A, Garcera S, et al. ESHAP is an active regimen for relapsing Hodgkin's disease. Ann Oncol, 1999, 10: 593-595.
  • 6Josting A, Rudolph C, Mapara M, et al. Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large muhicenter study of the German Hodgkin Lymphoma Study Group (GHSG). Ann Oncol, 2005, 16: 116-123.
  • 7Czyz J, Dziadziuszko R, Knopinska-Postuszuy W, et al. Outcome and prognostic factors in advanced Hodgkin's disease treated with high- dose chemotherapy and autologous stem cell transplantation: a study of 341 patients. Ann Oncol, 2004, 15: 1222-1230.
  • 8Evens A, Altman J, Mittal B, et al. Phase Ⅰ /Ⅱ trim of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphoma. Ann Oncol, 2007, 18: 679-688.
  • 9Bierman PJ, Lynch JC, Bociek RG, et al. The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for pre- dicting outcome of autologous hematopoietic stem cell transplantation. Ann Oncol, 2002, 13: 1370-1377.
  • 10Josting A, Franklin J, May M, et al. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group. J Clin Oncol, 2001, 20: 221-230.

共引文献2

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部